Belgium vs Northern Africa and Western Asia: Proportion of the target population who received the final dose of
Belgium
72.0%
in 2024
Northern Africa and Western Asia
2.0%
in 2024
Belgium rank
38th
Northern Africa and Western Asia rank
35th
Proportion of the target population who received the final dose of over time
- Belgium
- Northern Africa and Western Asia
How they compare
Belgium currently reports 72.0% against 2.0% in Northern Africa and Western Asia, a difference of 70.0%.
That makes Belgium's figure about 36.0 times Northern Africa and Western Asia's.
Across all 11 years both countries report, Belgium has been ahead every year.
Belgium ranks 38th and Northern Africa and Western Asia ranks 35th of 107 countries.
Belgium has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Northern Africa and Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 65.3% | 1.0% | 64.3% | Belgium |
| 2020s | 70.2% | 1.8% | 68.4% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Belgium or Northern Africa and Western Asia?
- Belgium, at 72.0% against 2.0% in Northern Africa and Western Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Belgium and Northern Africa and Western Asia?
- 70.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Northern Africa and Western Asia?
- 11 years are reported by both, from 2014 to 2024.
- How do Belgium and Northern Africa and Western Asia rank globally for proportion of the target population who received the final dose of?
- Belgium ranks 38th and Northern Africa and Western Asia ranks 35th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.